Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin (RASCIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00906529
Recruitment Status : Unknown
Verified May 2009 by University of Texas Southwestern Medical Center.
Recruitment status was:  Recruiting
First Posted : May 21, 2009
Last Update Posted : May 21, 2009
Novo Nordisk A/S
Information provided by:
University of Texas Southwestern Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2010
  Estimated Study Completion Date : March 2011